Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS Rosenson, AL Huskin, DA Wolff, IB Helenowski… - Atherosclerosis, 2008 - Elsevier
OBJECTIVE: To examine the effects of fenofibrate (160mg/d) therapy on fasting and
postprandial cytokine production in subjects with metabolic syndrome and …
被引用次数：48 相关文章

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS Rosenson, AL Huskin, DA Wolff… - …, 2008 - atherosclerosis-journal.com
Objective To examine the effects of fenofibrate (160mg/d) therapy on fasting and
postprandial cytokine production in subjects with metabolic syndrome and …

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.

RS Rosenson, AL Huskin, DA Wolff, IB Helenowski… - …, 2008 - europepmc.org
Objective To examine the effects of fenofibrate (160mg/d) therapy on fasting and
postprandial cytokine production in subjects with metabolic syndrome and …

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS Rosenson, AL Huskin, DA Wolff… - …, 2008 - scholars.northwestern.edu
Objective: To examine the effects of fenofibrate (160 mg/d) therapy on fasting and
postprandial cytokine production in subjects with metabolic syndrome and …

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS Rosenson, AL Huskin, DA Wolff, IB Helenowski… - Atherosclerosis, 2008 - infona.pl
To examine the effects of fenofibrate (160mg/d) therapy on fasting and postprandial cytokine
production in subjects with metabolic syndrome and hypertriglyceridemia. Randomized …

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS Rosenson, AL Huskin, DA Wolff, IB Helenowski… - 2008 - pubmed.ncbi.nlm.nih.gov
Objective To examine the effects of fenofibrate (160mg/d) therapy on fasting and
postprandial cytokine production in subjects with metabolic syndrome and …

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS Rosenson, AL Huskin, DA Wolff, IB Helenowski… - Atherosclerosis, 2008 - hero.epa.gov
Objective: To examine the effects of fenofibrate (160 mg/d) therapy on fasting and
postprandial cytokine production in subjects with metabolic syndrome and …
[PDF] academia.edu

[PDF][PDF] Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS Rosenson, AL Huskin, DA Wolff, IB Helenowski… - …, 2008 - academia.edu
Objective: To examine the effects of fenofibrate (160 mg/d) therapy on fasting and
postprandial cytokine production in subjects with metabolic syndrome and …

[引用][C] Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS ROSENSON, AL HUSKING, DA WOLFF… - …, 2008 - pascal-francis.inist.fr
Fenofibrate reduces fasting and postprandial inflammatory responses among
hypertriglyceridemia patients with the metabolic syndrome CNRS Inist Pascal-Francis …

[引用][C] Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome

RS ROSENSON, AL HUSKING, DA WOLFF… - Atherosclerosis, 2008 - Elsevier